White label – Pompe disease - ClinicalTrials.eu

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Not recruiting

2 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
- Xevinapant
+3
Study on AOC 1020 for Adults with Facioscapulohumeral Muscular Dystrophy (FSHD)

Not recruiting

2 1
Investigated Diseases:
- Facioscapulohumeral muscular dystrophy
Investigated Drugs:
- Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker
Study on the Safety and Effectiveness of Bemnifosbuvir and Ruzasvir for Patients with Chronic Hepatitis C

Not recruiting

2 1 1
Investigated Diseases:
- Chronic hepatitis C
Investigated Drugs:
- Bemnifosbuvir Hemisulfate
- Ruzasvir
Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Not recruiting

3 1 1 1
Investigated Drugs:
- Epoetin Alfa
- Luspatercept
+8
Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Endometrial cancer
Investigated Drugs:
- Gen1046
- Pembrolizumab
Study of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
- Lenvatinib
- Pembrolizumab
+3
Study on the Effectiveness of Ompenaclid with FOLFIRI and Bevacizumab for Patients with Advanced or Metastatic Colorectal Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Colorectal cancer
- Colorectal cancer metastatic
Investigated Drugs:
Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Transitional cell carcinoma
Study on the Safety and Effectiveness of MK-1308A, Pembrolizumab, and Lenvatinib for Patients with Advanced Liver Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
Study on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells for Treating Inflammatory Bowel Strictures in Crohn’s Disease Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies